The present invention relates to treating joint related conditions in
mammals by administering an aminosugar, and wherein said treatment
specifically prevents, lessens or reverses pathologies associated with
the joint condition, said pathologies being selected from the group
consisting of synovitis, subchondral bone edema, and cartilage
degradation.